A Retrospective Study of the Efficacy and Safety of Lolatinib in ALK+ NSCLC Patients With Brain or Meningeal Metastasis
Conditions: ALK-positive Non-small Cell Lung Cancer; Brain Metastases; Meningeal Metastasis Interventions: Drug: Lorlatinib Sponsors: Sichuan Cancer Hospital and Research Institute Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2024 Category: Research Source Type: clinical trials

Research on the Brain Mechanism of taVNS in Regulating PD Motor Symptoms
Conditions: Parkinson Disease Interventions: Device: Transcutaneous auricular vagus nerve stimulation Sponsors: The First Affiliated Hospital with Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2024 Category: Research Source Type: clinical trials

CE-STAND: Cervical Epidural STimulation After Neurologic Damage
Conditions: Cervical Spinal Cord Injury Interventions: Device: Epidural Spinal Cord Stimulation (eSCS) Sponsors: University of Minnesota Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2024 Category: Research Source Type: clinical trials

RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment
Conditions: Migraine; Migraine With Aura; Migraine Without Aura; Chronic Migraine Interventions: Drug: Rimegepant 75 mg Sponsors: University of Florence; IRCCS National Neurological Institute " C. Mondino " Foundation; Societ à italiana per lo studio delle Cefalee (SISC); Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari; Università degli Studi dell ' Aquila; University of Roma La Sapienza; Azienda Ospedaliero Universitaria Policlinico Modena; Ospedale di Piove di Sacco; Azienda Ospedaliero-Universitaria di Parma; Azienda Ospedaliera S. Maria della Misericordia; Azienda Ospedaliera Citt à della Salute e ...
Source: ClinicalTrials.gov - May 10, 2024 Category: Research Source Type: clinical trials

Effectiveness and Tolerability of Eptinezumab
Conditions: Migraine; Migraine With Aura; Migraine Without Aura; Chronic Migraine Interventions: Drug: Eptinezumab 100 or 300 mg ev Sponsors: University of Florence; Azienda Ospedaliero Universitaria Policlinico Modena; Societ à italiana per lo studio delle Cefalee (SISC); IRCCS National Neurological Institute " C. Mondino " Foundation; Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari; Universit à degli Studi dell ' Aquila; University of Roma La Sapienza; Euganea Health Unit, Padua, Italy; Azienda Ospedaliero-Universitaria di Parma; Azienda Ospedaliera S. Maria della Misericordia; Azienda Ospedaliera Cit...
Source: ClinicalTrials.gov - May 10, 2024 Category: Research Source Type: clinical trials

Intermediate Expanded Access Protocol CNMAu8.EAP04
Conditions: ALS; Amyotrophic Lateral Sclerosis; PALS Interventions: Drug: CNM-Au8 Sponsors: Clene Nanomedicine; National Institute of Neurological Disorders and Stroke (NINDS) Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2024 Category: Research Source Type: clinical trials

Muscle effects of neuromuscular electrostimulation in mechanically ventilated patients in an icu
Conditions: Intensive Care Unit Acquired Weakness Interventions: Device: neuromuscular electrical stimulation Sponsors: Universidade Federal do Rio de Janeiro; Hospital Universitario Pedro Ernesto Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2024 Category: Research Source Type: clinical trials

Neuromuscular Monitoring in Children (6 Months - 2 Years) With Electromyography and Acceleromyography
Conditions: Neuromuscular Blockade Interventions: Other: Acceleromyography (AMG); Other: Electromyography (EMG) Sponsors: Matias Vested Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2024 Category: Research Source Type: clinical trials

Multi-modal Training Program to Promote Physical Activity After Stroke: A Randomised Controlled Trial.
Conditions: Stroke; Physical Inactivity Interventions: Behavioral: Intervention group Sponsors: Singapore General Hospital; Singapore Institute of Technology; National Neuroscience Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2024 Category: Research Source Type: clinical trials

Effects of Pain Neuroscience Education and Virtual Reality in Patients With Chronic Low Back Pain
Conditions: Chronic Low-back Pain Interventions: Other: Pain Neuroscience Education + Virtual Reality + Therapeutic Exercise; Other: Therapeutic Exercise Sponsors: Universidad de Granada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2024 Category: Research Source Type: clinical trials

Active Young, Healthy Mind. The YoungFitT Project
Conditions: University Students Interventions: Behavioral: High-Intensity Functional Training (HIFT); Behavioral: Mindfulness-Based Stress Reduction Program (MBSR); Behavioral: Qigong Sponsors: University of Barcelona; University Ramon Llull; ICREA Academia; Institut de Neuroci ències de la Universitat de Barcelona; Institut de Recerca Sant Joan de Déu (CERCA center); EventLab; INEFC; Nirakara Lab; Adventhealth Research Institute, Neuroscience; University of Murdock Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2024 Category: Research Source Type: clinical trials

ATRX/DAXX in EUS-FNB Specimens of Pan-NETs
Conditions: Pancreatic Neuroendocrine Tumor Interventions: Diagnostic Test: ATRX/DAXX immunohistochemistry Sponsors: Azienda Ospedaliera Universitaria Integrata Verona Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2024 Category: Research Source Type: clinical trials

Brain-Controlled Spinal Stimulation Walking Therapy After Incomplete Spinal Cord Injury (SCI)
Conditions: Spinal Cord Injuries Interventions: Other: BCI-TSCS Sponsors: University of Miami Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2024 Category: Research Source Type: clinical trials

Perioperative Multimodal Analgesia Protocol for Supratentorial Craniotomy :a 2× 2 Factorial Randomized Clinical Trial
Conditions: Postoperative Pain, Acute; Analgesia; Supratentorial Brain Tumor Interventions: Drug: Dexmedetomidine; Drug: Normal saline; Other: Local analgesic techniques; Other: no Local analgesic techniques Sponsors: Beijing Tiantan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2024 Category: Research Source Type: clinical trials

A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
Conditions: Carcinoma, Neuroendocrine; Tumor, Neuroendocrine; Tumors, Neuroendocrine; Neuroendocrine; Carcinoma; Small Cell; Receptors Interventions: Drug: Belinostat; Drug: Cisplatin; Drug: Etoposide Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2024 Category: Research Source Type: clinical trials